Moderna
MRNA
#1403
Rank
A$23.74 B
Marketcap
A$60.77
Share price
2.47%
Change (1 day)
9.19%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Market capitalization of Moderna (MRNA)

Market cap: A$23.74 Billion

As of January 2026 Moderna has a market cap of A$23.74 Billion. This makes Moderna the world's 1403th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Moderna from 2018 to 2026

End of year Market Cap

Year Marketcap Change
2026A$23.74 B30.47%
2025A$18.20 B-26.69%
2024A$24.82 B-55.39%
2023A$55.65 B-45.11%
2022A$101.40 B-28.61%
2021A$142.03 B164.2%
2020A$53.76 B471.83%
2019A$9.40 B31.92%
2018A$7.12 B

End of Day market cap according to different sources

On Jan 14th, 2026 the market cap of Moderna was reported to be:

A$23.74 Billion
by Nasdaq info icon info icon
A$23.74 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Regulus Therapeutics
RGLS
A$0.84 B-96.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$415.25 B 1,648.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
A$1.24 M-99.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
A$72.58 B 205.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
A$420.00 B 1,668.74%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Arrowhead Pharmaceuticals
ARWR
A$13.76 B-42.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
A$788.56 B 3,220.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
A$4.45 B-81.22%๐Ÿ‡บ๐Ÿ‡ธ USA